Search - tctmd.com

Displaying 281 - 300 of 970

Sort: Relevancy | Date

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Presenter: Aloke Finn

September 18, 2022

Presentation TCT 2022

Introduction & Session Objectives

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Presenter: John Shulze

September 18, 2022

Presentation TCT 2022

TCT 177: Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: Final 2-Year Results from the Disrupt CAD III Study

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

Presenter: Davide Capodanno

September 18, 2022

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

Presentation TCT 2022

Case-Based Presentation: Sex-Specific Considerations of Physiologic Assessment of CAD in the Cath Lab

Presenter: Rasha Al-Lamee

September 17, 2022

Presentation TCT 2022

Keynote Speech: Diagnosis and Treatment of CAD in Women – The Role of Social Determinant of Health

Presenter: Clyde Yancy

September 17, 2022

Presentation TCT 2022

Management of Coronary Artery Disease in CLTI? Is That the Ticket?

Presenter: Christopher Zarins

September 17, 2022

Presentation TCT 2022

Case #1: Multivessel Coronary Artery Disease

Presenter: Aakriti Gupta

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

Presentation TCT 2021

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

Presenter: IN-HO CHAE

November 06, 2021

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

Presentation TCT 2021

BIO-RISE CHINA: A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease

Presenter: Yaling Han

November 06, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

Advertisement

DCB in CAD: understanding the existing and new indications

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Introduction & Session Objectives

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

TCT 177: Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: Final 2-Year Results from the Disrupt CAD III Study

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Case-Based Presentation: Sex-Specific Considerations of Physiologic Assessment of CAD in the Cath Lab

Keynote Speech: Diagnosis and Treatment of CAD in Women – The Role of Social Determinant of Health

Management of Coronary Artery Disease in CLTI? Is That the Ticket?

Case #1: Multivessel Coronary Artery Disease

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease

DCBs in Coronaries? Some Good News, but More Work Needed

BIO-RISE CHINA: A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content